Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Westlake Biopartners Opportunity Fund I, L.P.

10% Owner at Kyverna Therapeutics, Inc. (KYTX)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-3.0%
vs. S&P 500+1.1%
Beat the market100%
Paper profit on buys−$148K
Total bought / sold$1000K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 22SEC KYTXKyverna Therapeutics, Inc. Buy 133,333869,317 held (+18%) $7.50 $1000K -14.8%
  • Buy

    10% Owner Westlake Biopartners Opportunity Fund I, L.P. bought $1000K of KYTX at $7.50 — first open-market purchase in our records.